The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
Open accessAbstract
Artificial intelligence models using digital histopathology slides stained with hematoxylin and eosin offer promising, tissue-preserving diagnostic tools for patients with cancer. Despite their advantages, their clinical utility in real-world settings remains unproven. Assessing EGFR mutations in lung adenocarcinoma demands rapid, accurate and cost-effective tests that preserve tissue for genomic sequencing. PCR-based assays provide rapid results but with reduced accuracy compared with next-generation sequencing and require additional tissue. Computational biomarkers leveraging modern foundation models can address these limitations. Here we assembled a large international clinical dataset of digital lung adenocarcinoma slides ( N = 8,461) to develop a computational EGFR biomarker. Our model fine-tunes an open-source foundation model, improving task-specific performance with out-of-center generalization and clinical-grade accuracy on primary and metastatic specimens (mean area under the curve: internal 0.847, external 0.870). To evaluate real-world clinical translation, we conducted a prospective silent trial of the biomarker on primary samples, achieving an area under the curve of 0.890. The artificial-intelligence-assisted workflow reduced the number of rapid molecular tests needed by up to 43% while maintaining the current clinical standard performance. Our retrospective and prospective analyses demonstrate the real-world clinical utility of a computational pathology biomarker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, translating the capabilities of current patch-based foundation models to address patient- and slide-level clinical challenges still remains complex due to the immense scale of gigapixel WSIs, compounded by the small size of patient cohorts in real-world evidence39–42, especially for rare diseases with limited training data43–45.”
From A multimodal whole-slide foundation model for pathology (2025) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale
Dosovitskiy, A., Beyer, L., Kolesnikov, A., Weissenborn, D., Zhai, X., Unterthiner, T., Dehghani, M., Minderer, M., Heigold, G., Gelly, S., et al. (2020) · arXiv · doi:10.48550/arxiv.2010.11929 · Cited by 47,472
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380 · cited 2×
“Importantly, mutations outside of the EGFR kinase domain (exons 18–24) are not oncogenic and are excluded from the analysis.”
Self-citationCoudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930 · cited 3×
“In the context of EGFR prediction in LUAD, the seminal work of Coudray et al. 11 reported early results on the value of histology for this task.”
InfluentialOncoKB: A Precision Oncology Knowledge Base
Chakravarty, D., Gao, J., Phillips, S., Kundra, R., Zhang, H., Wang, J., Rudolph, J. E., Yaeger, R., Soumerai, T., Nissan, M. H., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00011 · Cited by 2,589 · cited 1×
“EGFR mutations from WES were clinically characterized using the OncoKB database 22 .”
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Towards a general-purpose foundation model for computational pathology
Chen, R. J., Ding, T., Lu, M. Y., Williamson, D. F. K., Jaume, G., Song, A. H., Chen, B., Zhang, A., Shao, D., Shaban, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02857-3 · Cited by 1,560
Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0388-cp · Cited by 936
Self-citation
Cited by
A multimodal whole-slide foundation model for pathology
Ding, T., Wagner, S. J., Song, A. H., Chen, R. J., Lu, M. Y., Zhang, A., Vaidya, A. J., Jaume, G., Shaban, M., Kim, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03982-3 · Cited by 171
Application of artificial intelligence and digital tools in cancer pathology
Shaktah, L., Carrero, Z. I., Hewitt, K. J., Gustav, M., Cecchini, M. J., Foersch, S., Berezowska, S., & Kather, J. N. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.100933 · Cited by 50
Confounding factors and biases abound when predicting molecular biomarkers from histological images
Dawood, M., Branson, K., Tejpar, S., Rajpoot, N., & Minhas, F. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01616-8 · Cited by 24
“5 and 7).”
A scoping review of silent trials for medical artificial intelligence
Tikhomirov, L., Semmler, C., Prizant, N., Bhasin, S., Kenyon, G., van der Vegt, A., Erdman, L., Kurian, N. C., Thompson, H., Palmer, L. J., et al. (2026) · Nature Health · doi:10.1038/s44360-025-00048-z · Cited by 17
Cheng, H., & Wong, C. C. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03592-4 · Cited by 18
“Integration of this AI-assisted workflow into clinical practice reduced the need for rapid molecular testing by up to 43%, while preserving established standards of diagnostic performance [85].”
Metadata
- Authors
- Campanella, G., Kumar, N., Nanda, S., Singi, S., Fluder, E., Kwan, R., Muehlstedt, S., Pfarr, N., Schüffler, P. J., Häggström, I., Neittaanmäki, N., Akyürek, L. M., Basnet, A., Jamaspishvili, T., Nasr, M. R., Croken, M. M., Hirsch, F. R., Elkrief, A., Yu, H., Ardon, O., Goldgof, G. M., Hameed, M., Houldsworth, J., Arcila, M., Fuchs, T. J., & Vanderbilt, C.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Memorial Sloan Kettering Cancer Center (US)
- Technical University of Munich (DE)
- Chalmers University of Technology (SE)
- Sahlgrenska University Hospital (SE)
- SUNY Upstate Medical University (US)
- Tisch Cancer Institute (US)
- Université de Montréal (CA)
- Corresponding author
- Fuchs, Thomas J.
- Vanderbilt, Chad
- ORCID
- Campanella, Gabriele
- Kumar, Neeraj
- Singi, Siddharth
- Pfarr, Nicole
- Schüffler, Peter J.
- Häggström, Ida
- Neittaanmäki, Noora
- Akyürek, Levent M.
- Basnet, Alina
- Jamaspishvili, Tamara
- Nasr, Michel R.
- Croken, Matthew M.
- Hirsch, Fred R.
- Elkrief, Arielle
- Yu, Helena
- Ardon, Orly
- Goldgof, Gregory M.
- Hameed, Meera
- Houldsworth, Jane
- Arcila, Maria
- Fuchs, Thomas J.
- Vanderbilt, Chad
- Venue
- Nature Medicine
- Published
- 2025-07-09
- Volume
- 31
- Issue
- 9
- Pages
- 3002-3010
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC12443599
- OpenAlex
- W4412151081
- Semantic Scholar
- 5d022ea5c09b07e0d175f9f3b3019f779d76c3d1
- Cited by
- 69
- References
- 19
- Citations by year
- 2026: 59 · 2025: 10
- FWCI
- 27.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Chalmers Research (Chalmers University of Technology) (submittedVersion)
- Funders
- Warren Alpert Foundation
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
- Topics
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- EGFR mutation testing, lung adenocarcinoma, digital histopathology, computational pathology, pathology foundation models, fine-tuning, metastatic lung cancer, clinical translation, rapid molecular diagnostics, H&E staining
- MeSH terms
- Adenocarcinoma of Lung, Artificial Intelligence, Female, Humans, Lung Neoplasms, Male, Mutation, Biomarkers, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection. https://app.cochat.ai/papers/10.1038/s41591-025-03780-x
- The paper
- Campanella, G., Kumar, N., Nanda, S., Singi, S., Fluder, E., Kwan, R., Muehlstedt, S., Pfarr, N., Schüffler, P. J., Häggström, I., Neittaanmäki, N., Akyürek, L. M., Basnet, A., Jamaspishvili, T., Nasr, M. R., Croken, M. M., Hirsch, F. R., Elkrief, A., Yu, H., . . . Vanderbilt, C. (2025). Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection. Nature Medicine. https://doi.org/10.1038/s41591-025-03780-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.